Landiolol is effective and safe in paediatric supraventricular tachycardia: Evidence from a European prospective multicentre open-label Phase III study (LANDI-PED)
{{output}}
Background and aims: Landiolol, an ultra-fast acting super-selective beta-blocker, was investigated for the first time in Europe in a prospective clinical study for the management of supraventricular tachycardia (SVT) among paedi... ...
